Korngold R, Sprent J
J Exp Med. 1982 Mar 1;155(3):872-83. doi: 10.1084/jem.155.3.872.
Evidence is presented that T cells that produce lethal graft-vs.-host disease (GVHD) to minor histocompatibility antigens (minor HA) comprise discrete subgroups of H-2K- and H-2D-restricted T cells; double negative selection of T cells in irradiated H-2 recombinant mice was used to separate these two subgroups. No evidence could be found that I-restricted T cells contributed to GVHD, either as effector cells or helper cells. The (unprimed) precursor cells for GVHD expressed the Thy-1+, Lyt-1+/-2, Ia- phenotype. Studies in which H-2-semiallogeneic bone marrow chimeras were used as hosts for negative selection suggested that presentation of minor HA to T cells during the induction phase is controlled by marrow-derived cells; indirect evidence was obtained that these latter cells can "process" minor HA presented on H-2 different cells and thereby render the antigens immunogenic. Studies in which minor HA-different, H-2-compatible chimeras were re-irradiated and then injected with donor-vs.-host T cells suggested that the effector phase of lethal GVHD involves contact of antigen on non-marrow-derived cells.
有证据表明,对次要组织相容性抗原(次要HA)产生致死性移植物抗宿主病(GVHD)的T细胞包含H-2K-和H-2D限制性T细胞的离散亚群;利用照射后的H-2重组小鼠中T细胞的双阴性选择来分离这两个亚群。未发现I限制性T细胞作为效应细胞或辅助细胞参与GVHD的证据。GVHD的(未致敏)前体细胞表现为Thy-1+、Lyt-1+/-2、Ia-表型。将H-2半同种异体骨髓嵌合体用作阴性选择宿主的研究表明,诱导期次要HA向T细胞的呈递受骨髓来源细胞控制;获得的间接证据表明,这些后者细胞可以“处理”呈递在H-2不同细胞上的次要HA,从而使抗原具有免疫原性。对次要HA不同、H-2相容的嵌合体再次照射,然后注射供体对宿主T细胞的研究表明,致死性GVHD的效应期涉及非骨髓来源细胞上抗原的接触。